OncoHealth appoints Jon Maack as CEO, succeeding Rick Dean, who transitions to an advisory role. Maack brings decades of healthcare IT experience to lead the company's continued growth in oncology management.
ATLANTA, Feb. 11, 2025 /PRNewswire-PRWeb/ -- OncoHealth®, the leading platform for managing the cost and complexity of cancer and a portfolio company of Arsenal Capital Partners ("Arsenal"), today announced that Jon Maack will succeed Rick Dean as the company's Chief Executive Officer.
After seven years of leadership, Rick Dean will transition from CEO to an advisory role and continue to serve on the Board of Directors. Under his leadership, OncoHealth experienced remarkable growth, expanding its customer base and the scope of its offerings. In the past year alone, the company continued its upward trajectory, now serving over 14 million lives across 20 health plan customers.
Jon Maack brings more than two decades of experience in healthcare IT and services, with leadership roles at the Advisory Board Company, Optum, athenahealth and, most recently, as President of Definitive Healthcare. He has a proven track record of helping organizations scale with an extensive background in the core processes of healthcare—from revenue cycle management to physician workflow. As CEO, Mr. Maack is committed to advancing OncoHealth's mission by leveraging utilization management, virtual cancer support, and clinical consultations to reduce the physical, mental, and financial toll of cancer on patients and their families.
Scott Blanchette, Chairman of OncoHealth and Director of Arsenal stated, "We are excited to welcome Jon Maack as OncoHealth's new CEO. With over 20 years of experience in scaling healthcare IT and services, Jon is the ideal leader to guide the company into its next chapter of innovation and impact. We also extend our deepest gratitude to Rick Dean for his outstanding leadership and unwavering dedication and look forward to continued collaboration with him as a board member."
"It has been a tremendous honor to lead OncoHealth over the past seven years," shared Rick Dean. "I am deeply proud of the team we've built and the impact we've made in supporting patients and health plans. I have full confidence that Jon will continue to drive the company forward, building upon our strong foundation."
Jon Maack expressed, "I am honored to join OncoHealth at such a pivotal moment in its growth. Cancer care is a deeply personal and complex journey, and I look forward to working alongside our talented team, valued customers, dedicated clinicians, and the patients we serve to deliver a better experience for those battling this disease."
About OncoHealth
OncoHealth is dedicated to helping health plans, employers, oncologists, and patients navigate the physical, mental, and financial complexities of cancer. Focused 100% on oncology, OncoHealth's market-leading software and services platform delivers the industry's first integrated oncology management solution to ensure people with cancer are getting the most appropriate treatment and support. Powered the nation's first oncology focused 50-state virtual medical group, OncoHealth combines industry leading oncology management with services including 24/7 oncology nursing, mental health, nutrition, and resource navigation to drive impact for our customers and positive outcomes for our patients. To learn more, visit www.oncohealth.us.
About Arsenal Capital Partners
Arsenal Capital Partners is a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 300 platform and add-on acquisitions, and achieved more than 35 realizations. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add. For more information, visit www.arsenalcapital.com.
Media Contact:
Brett Erhardt for OncoHealth
Ellen Pavlovsky for Arsenal Capital Partners
Media Contact
Brett Erhardt, OncoHealth, 1 888.916.2616, [email protected], www.oncohealth.us
SOURCE OncoHealth
Share this article